Search

Roxithromycin

It is marketed in Australia as a treatment for respiratory tract, urinary and soft tissue infections.

Allocetra

With infusion, the body's macrophages and dendritic cells can feed on these early apoptotic Allocetra cells and thus result in the macrophages and dendritic cells releasing fewer cytokine alert signals … Allocetra is a novel therapy where billions of early apoptotic cells are infused into the bloodstream of a patient, using the body's own natural regulation mechanisms to rebalance an unbalanced immune

Arsthinol

Arsthinol (INN) is an antiprotozoal agent that was first synthesized by Ernst A.H. Friedheim in 1949 via the complexing of acetarsol with 2,3-dimercaptopropanol.

MRx-4DP0004

MRx-4DP0004 is a lyophilised formulation of the Bifidobacterium breve strain of commensal bacteria. It is a live biotherapeutic derived from the microbiota of a healthy human infant.

Elvucitabine

Briakinumab

As of 2011 drug development for psoriasis has been discontinued in the U.S. and Europe.

Reposal

Reposal is a barbiturate derivative invented in the 1960s in Denmark that has sedative, hypnotic and anticonvulsant properties. It was used primarily in the treatment of insomnia.

Human interleukin-6

Human interleukin-6 is under investigation in clinical trial NCT03170245 (Adiponectin, IL-6 and hsC-RP in Relation to Carotid Intima-media Thickness in B-thalassemia Patients).

NV1020

NV1020, a genetically engineered herpes simplex virus, is a novel anticancer therapeutic.

Zaltoprofen

A non-steroidal anti-inflammatory drug approved for use in Japan in 1993.